NPAS3 is also known to regulate transcriptional levels of VGF [137–139] which is a key regulator in protection against AD pathogenesis in 5xFAD mice models [117] and a top target identified by the AMP-AD consortium (agora.adknowledgeportal.org/). Here, NPAS3 is linked to Alzheimer disease.